300723 一品红
已收盘 07-18 15:00:00
资讯
新帖
简况
7月17日一品红涨5.96%,长城医药产业精选混合发起式A基金重仓该股
证券之星 · 07-17 08:19
7月17日一品红涨5.96%,长城医药产业精选混合发起式A基金重仓该股
7月14日一品红涨5.87%,长城医药产业精选混合发起式A基金重仓该股
证券之星 · 07-14
7月14日一品红涨5.87%,长城医药产业精选混合发起式A基金重仓该股
高血压概念盘中拉升,一品红涨4.58%
市场透视 · 07-10
高血压概念盘中拉升,一品红涨4.58%
7月7日一品红跌6.38%,安信医药健康股票A基金重仓该股
证券之星 · 07-07
7月7日一品红跌6.38%,安信医药健康股票A基金重仓该股
一品红(300723)6月30日股东户数1.71万户,较上期增加36.61%
证券之星 · 07-01
一品红(300723)6月30日股东户数1.71万户,较上期增加36.61%
7月1日一品红涨14.72%,安信医药健康股票A基金重仓该股
证券之星 · 07-01
7月1日一品红涨14.72%,安信医药健康股票A基金重仓该股
6月23日一品红涨5.10%,安信医药健康股票A基金重仓该股
证券之星 · 06-23
6月23日一品红涨5.10%,安信医药健康股票A基金重仓该股
一品红(300723.SZ):注射用唑来膦酸浓溶液获得药品注册证书
智通财经 · 06-23
一品红(300723.SZ):注射用唑来膦酸浓溶液获得药品注册证书
一品红(300723)股东李捍东质押409万股,占总股本0.91%
证券之星 · 06-20
一品红(300723)股东李捍东质押409万股,占总股本0.91%
6月17日一品红跌10.82%,安信医药健康股票A基金重仓该股
证券之星 · 06-17
6月17日一品红跌10.82%,安信医药健康股票A基金重仓该股
每周股票复盘:一品红(300723)全资子公司获盐酸右美托咪定注射液注册证书
证券之星 · 06-13
每周股票复盘:一品红(300723)全资子公司获盐酸右美托咪定注射液注册证书
6月11日一品红跌5.29%,安信医药健康股票A基金重仓该股
证券之星 · 06-11
6月11日一品红跌5.29%,安信医药健康股票A基金重仓该股
中证1000医药卫生指数报12030.35点,前十大权重包含一品红等
金融界 · 06-10
中证1000医药卫生指数报12030.35点,前十大权重包含一品红等
一品红上涨6.86%,报60.59元/股
金融界 · 06-10
一品红上涨6.86%,报60.59元/股
一品红(300723.SZ)子公司获得盐酸右美托咪定注射液注册证书
智通财经 · 06-09
一品红(300723.SZ)子公司获得盐酸右美托咪定注射液注册证书
6月9日一品红涨9.95%,安信医药健康股票A基金重仓该股
证券之星 · 06-09
6月9日一品红涨9.95%,安信医药健康股票A基金重仓该股
一品红最新公告:全资子公司获得羧甲司坦口服溶液注册证书
证券之星 · 06-04
一品红最新公告:全资子公司获得羧甲司坦口服溶液注册证书
一品红最新公告:全资子公司获得间苯三酚注射液注册证书
证券之星 · 06-04
一品红最新公告:全资子公司获得间苯三酚注射液注册证书
每周股票复盘:一品红(300723)全资子公司取得药品生产许可证
证券之星 · 05-31
每周股票复盘:一品红(300723)全资子公司取得药品生产许可证
一品红最新公告:全资子公司瑞石制药取得药品生产许可证
证券之星 · 05-28
一品红最新公告:全资子公司瑞石制药取得药品生产许可证
加载更多
公司概况
公司名称:
一品红药业集团股份有限公司
所属行业:
医药制造业
上市日期:
2017-11-16
主营业务:
一品红药业集团股份有限公司的主营业务是药品的研发、生产和销售。公司的主要产品是化学药(含原料药和制剂)、特色中成药等。
发行价格:
17.05
{"stockData":{"symbol":"300723","market":"SZ","secType":"STK","nameCN":"一品红","latestPrice":67.11,"timestamp":1752822231000,"preClose":66.01,"halted":0,"volume":10527237,"delay":0,"changeRate":0.0167,"floatShares":418000000,"shares":451999999,"eps":-1.2929,"marketStatus":"已收盘","change":1.1,"latestTime":"07-18 15:00:00","open":66.01,"high":68.08,"low":63.97,"amount":698000000,"amplitude":0.0623,"askPrice":67.12,"askSize":110,"bidPrice":67.11,"bidSize":5,"shortable":0,"etf":0,"ttmEps":-1.2929,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753061400000},"marketStatusCode":5,"adr":0,"adjPreClose":66.01,"symbolType":"stock","openAndCloseTimeList":[[1752802200000,1752809400000],[1752814800000,1752822000000]],"highLimit":72.61,"lowLimit":59.41,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":451692766,"isCdr":false,"pbRate":15.41,"roa":"--","roe":"2.97%","epsLYR":-1.1956,"committee":0.104536,"marketValue":30313000000,"turnoverRate":0.0252,"status":0,"floatMarketCap":28028000000},"requestUrl":"/m/hq/s/300723","defaultTab":"news","newsList":[{"id":"2552326104","title":"7月17日一品红涨5.96%,长城医药产业精选混合发起式A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2552326104","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552326104?lang=zh_cn&edition=full","pubTime":"2025-07-17 16:19","pubTimestamp":1752740380,"startTime":"0","endTime":"0","summary":"证券之星消息,7月17日一品红涨5.96%创60日新高,收盘报66.01元,换手率3.81%,成交量15.9万手,成交额10.25亿元。根据2025基金半年报公募基金重仓股数据,重仓该股的公募基金共4家,其中持有数量最多的公募基金为长城基金的长城医药产业精选混合发起式A。长城医药产业精选混合发起式A目前规模为2.04亿元,最新净值1.9503,较上一交易日上涨0.86%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071700024655.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300723","BK0239"],"gpt_icon":0},{"id":"2551090510","title":"7月14日一品红涨5.87%,长城医药产业精选混合发起式A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2551090510","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551090510?lang=zh_cn&edition=full","pubTime":"2025-07-14 16:21","pubTimestamp":1752481291,"startTime":"0","endTime":"0","summary":"证券之星消息,7月14日一品红涨5.87%,收盘报53.77元,换手率3.18%,成交量13.29万手,成交额7.02亿元。根据2025基金半年报公募基金重仓股数据,重仓该股的公募基金共4家,其中持有数量最多的公募基金为长城基金的长城医药产业精选混合发起式A。长城医药产业精选混合发起式A目前规模为2.04亿元,最新净值1.8109,较上一交易日上涨3.17%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071400021722.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300723","BK0239"],"gpt_icon":0},{"id":"2550263693","title":"高血压概念盘中拉升,一品红涨4.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550263693","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550263693?lang=zh_cn&edition=full","pubTime":"2025-07-10 10:11","pubTimestamp":1752113517,"startTime":"0","endTime":"0","summary":"07月10日,高血压概念盘中拉升,截至10点11分,高血压概念整体指数上涨1.04%,报1451.900点。从个股上来看,该概念的成分股中,一品红涨4.58%,向日葵、立方制药、XD华海药涨幅居前。从资金上来看,截止发稿,高血压概念主力净流入为8205.91万,其中恒瑞医药受到资金热捧,主力净流入5993.48万;拉长时间线来看,该板块近20日主力资金净流入-15.84亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710101157a44174ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710101157a44174ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1997245177.USD","600276","BK0028","LU0405327148.USD","LU1655091616.SGD","BK0012","BK0060","LU2328871848.SGD","300723","BK0239","LU1328615791.USD","LU2495084118.USD","BK0188","LU1064131003.USD","BK0196","LU0405327494.USD","LU1997245094.SGD","BK0183","LU2148510915.USD","LU2488822045.USD","LU1969619763.USD","LU1997244956.HKD","LU1064130708.USD"],"gpt_icon":0},{"id":"2549589961","title":"7月7日一品红跌6.38%,安信医药健康股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2549589961","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549589961?lang=zh_cn&edition=full","pubTime":"2025-07-07 16:26","pubTimestamp":1751876778,"startTime":"0","endTime":"0","summary":"证券之星消息,7月7日一品红跌6.38%,收盘报53.0元,换手率2.92%,成交量12.21万手,成交额6.54亿元。根据2025基金Q1季报公募基金重仓股数据,重仓该股的公募基金共36家,其中持有数量最多的公募基金为安信基金的安信医药健康股票A。安信医药健康股票A目前规模为5.89亿元,最新净值1.3074,较上一交易日下跌0.02%,近一年上涨47.16%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070700020905.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300723"],"gpt_icon":0},{"id":"2548074457","title":"一品红(300723)6月30日股东户数1.71万户,较上期增加36.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548074457","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548074457?lang=zh_cn&edition=full","pubTime":"2025-07-01 17:18","pubTimestamp":1751361520,"startTime":"0","endTime":"0","summary":"证券之星消息,近日一品红披露,截至2025年6月30日公司股东户数为1.71万户,较4月30日增加4586.0户,增幅为36.61%。在化学制药行业个股中,一品红股东户数低于行业平均水平,截至6月30日,化学制药行业平均股东户数为3.28万户。从股价来看,2025年4月30日至2025年6月30日,一品红区间涨幅为25.83%,在此期间股东户数增加4586.0户,增幅为36.61%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070100028848.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300723"],"gpt_icon":0},{"id":"2548141079","title":"7月1日一品红涨14.72%,安信医药健康股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2548141079","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548141079?lang=zh_cn&edition=full","pubTime":"2025-07-01 16:29","pubTimestamp":1751358555,"startTime":"0","endTime":"0","summary":"证券之星消息,7月1日一品红涨14.72%,收盘报57.5元,换手率5.65%,成交量23.6万手,成交额12.71亿元。根据2025基金Q1季报公募基金重仓股数据,重仓该股的公募基金共36家,其中持有数量最多的公募基金为安信基金的安信医药健康股票A。安信医药健康股票A目前规模为5.89亿元,最新净值1.2433,较上一交易日上涨1.47%,近一年上涨33.56%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070100026831.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300723","BK0239"],"gpt_icon":0},{"id":"2545496819","title":"6月23日一品红涨5.10%,安信医药健康股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2545496819","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545496819?lang=zh_cn&edition=full","pubTime":"2025-06-23 16:28","pubTimestamp":1750667312,"startTime":"0","endTime":"0","summary":"证券之星消息,6月23日一品红涨5.10%,收盘报51.33元,换手率3.07%,成交量12.8万手,成交额6.43亿元。根据2025基金Q1季报公募基金重仓股数据,重仓该股的公募基金共36家,其中持有数量最多的公募基金为安信基金的安信医药健康股票A。安信医药健康股票A目前规模为5.89亿元,最新净值1.2012,较上一交易日上涨0.2%,近一年上涨24.7%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062300019217.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300723","BK0239"],"gpt_icon":0},{"id":"2545661954","title":"一品红(300723.SZ):注射用唑来膦酸浓溶液获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2545661954","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545661954?lang=zh_cn&edition=full","pubTime":"2025-06-23 12:00","pubTimestamp":1750651220,"startTime":"0","endTime":"0","summary":"智通财经APP讯,一品红 发布公告,公司全资子公司广州市联瑞制药有限公司于近日收到国家药品监督管理局核准签发的关于注射用唑来膦酸浓溶液的《药品注册证书》,涉及产品:“注射用唑来膦酸浓溶液”。注射用唑来膦酸浓溶液适应症为:与标准抗肿瘤药物治疗合用,用于治疗实体肿瘤骨转移患者和多发性骨髓瘤患者的骨骼损害。唑来膦酸的主要药理作用是抑制骨重吸收。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1308293.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"一品红(300723.SZ):注射用唑来膦酸浓溶液获得药品注册证书","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","300723"],"gpt_icon":0},{"id":"2544126923","title":"一品红(300723)股东李捍东质押409万股,占总股本0.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544126923","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544126923?lang=zh_cn&edition=full","pubTime":"2025-06-20 18:25","pubTimestamp":1750415155,"startTime":"0","endTime":"0","summary":"证券之星消息,一品红6月20日公开信息显示,股东李捍东向招商证券股份有限公司合计质押409.0万股,占总股本0.91%。质押详情见下表:截止本公告日,股东吴美容已累计质押股份1699.1万股,占其持股总数的66.67%,股东李捍东已累计质押股份824.0万股,占其持股总数的60.42%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062000030125.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300723","BK0239"],"gpt_icon":0},{"id":"2544315951","title":"6月17日一品红跌10.82%,安信医药健康股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2544315951","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544315951?lang=zh_cn&edition=full","pubTime":"2025-06-17 16:27","pubTimestamp":1750148860,"startTime":"0","endTime":"0","summary":"证券之星消息,6月17日一品红跌10.82%,收盘报51.37元,换手率4.93%,成交量20.57万手,成交额11.08亿元。根据2025基金Q1季报公募基金重仓股数据,重仓该股的公募基金共36家,其中持有数量最多的公募基金为安信基金的安信医药健康股票A。安信医药健康股票A目前规模为5.89亿元,最新净值1.3142,较上一交易日下跌1.09%,近一年上涨31.26%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061700024277.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300723"],"gpt_icon":0},{"id":"2543795658","title":"每周股票复盘:一品红(300723)全资子公司获盐酸右美托咪定注射液注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2543795658","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543795658?lang=zh_cn&edition=full","pubTime":"2025-06-14 05:27","pubTimestamp":1749850036,"startTime":"0","endTime":"0","summary":"本周关注点一品红全资子公司获得盐酸右美托咪定注射液注册证书公司公告汇总一品红药业集团股份有限公司全资子公司广州一品红制药有限公司近日收到国家药品监督管理局核准签发的盐酸右美托咪定注射液《药品注册证书》。审批结论表明该药品符合注册要求,批准注册并发放药品注册证书。备查文件包括《盐酸右美托咪定注射液药品注册证书》和《盐酸右美托咪定注射液说明书》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061400008487.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300723"],"gpt_icon":0},{"id":"2542305015","title":"6月11日一品红跌5.29%,安信医药健康股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2542305015","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542305015?lang=zh_cn&edition=full","pubTime":"2025-06-11 16:26","pubTimestamp":1749630413,"startTime":"0","endTime":"0","summary":"证券之星消息,6月11日一品红跌5.29%,收盘报58.75元,换手率3.55%,成交量14.84万手,成交额8.75亿元。根据2025基金Q1季报公募基金重仓股数据,重仓该股的公募基金共36家,其中持有数量最多的公募基金为安信基金的安信医药健康股票A。安信医药健康股票A目前规模为5.89亿元,最新净值1.3559,较上一交易日上涨2.77%,近一年上涨34.61%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061100024257.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300723","BK0239"],"gpt_icon":0},{"id":"2542393604","title":"中证1000医药卫生指数报12030.35点,前十大权重包含一品红等","url":"https://stock-news.laohu8.com/highlight/detail?id=2542393604","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542393604?lang=zh_cn&edition=full","pubTime":"2025-06-10 15:38","pubTimestamp":1749541126,"startTime":"0","endTime":"0","summary":"金融界6月10日消息,上证指数高开低走,中证1000医药卫生指数 报12030.35点。数据统计显示,中证1000医药卫生指数近一个月上涨9.20%,近三个月上涨8.07%,年至今上涨12.01%。从中证1000医药卫生指数持仓样本的行业来看,化学药占比29.34%、医疗器械占比21.62%、生物药品占比18.91%、中药占比18.81%、医疗商业与服务占比7.10%、制药与生物科技服务占比4.22%。在样本有特殊事件发生,导致其行业归属发生变更时,将对中证1000行业指数样本进行相应调整。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/06/10153850972624.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["399852","300723","159845","BK0239","000001.SH","000852.SH"],"gpt_icon":0},{"id":"2542632933","title":"一品红上涨6.86%,报60.59元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2542632933","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542632933?lang=zh_cn&edition=full","pubTime":"2025-06-10 11:21","pubTimestamp":1749525685,"startTime":"0","endTime":"0","summary":"6月10日,一品红盘中上涨6.86%,截至11:21,报60.59元/股,成交7.82亿元,换手率3.33%,总市值273.68亿元。截至4月30日,一品红股东户数1.25万,人均流通股3.33万股。2025年1月-3月,一品红实现营业收入3.77亿元,同比减少39.48%;归属净利润5658.85万元,同比减少43.70%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/06/10112150966304.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["300723","BK0239"],"gpt_icon":0},{"id":"2542152807","title":"一品红(300723.SZ)子公司获得盐酸右美托咪定注射液注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2542152807","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542152807?lang=zh_cn&edition=full","pubTime":"2025-06-09 17:27","pubTimestamp":1749461262,"startTime":"0","endTime":"0","summary":"智通财经APP讯,一品红(300723.SZ)发布公告,公司全资子公司广州一品红制药有限公司于近日收到国家药品监督管理局核准签发的关于盐酸右美托咪定注射液的《药品注册证书》。此次公司获得盐酸右美托咪定注射液注册证书,标志着公司具备了在国内市场销售该规格药品的资格,将进一步丰富公司产品管线和产品品类,增强了公司的核心竞争力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1302960.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300723","BK0239"],"gpt_icon":0},{"id":"2542027809","title":"6月9日一品红涨9.95%,安信医药健康股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2542027809","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542027809?lang=zh_cn&edition=full","pubTime":"2025-06-09 16:31","pubTimestamp":1749457890,"startTime":"0","endTime":"0","summary":"证券之星消息,6月9日一品红涨9.95%创60日新高,收盘报56.7元,换手率4.38%,成交量18.29万手,成交额10.24亿元。根据2025基金Q1季报公募基金重仓股数据,重仓该股的公募基金共36家,其中持有数量最多的公募基金为安信基金的安信医药健康股票A。安信医药健康股票A目前规模为5.89亿元,最新净值1.2566,较上一交易日上涨0.96%,近一年上涨24.26%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060900020304.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300723","BK0239"],"gpt_icon":0},{"id":"2540068853","title":"一品红最新公告:全资子公司获得羧甲司坦口服溶液注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2540068853","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540068853?lang=zh_cn&edition=full","pubTime":"2025-06-04 19:10","pubTimestamp":1749035425,"startTime":"0","endTime":"0","summary":"一品红(300723.SZ)公告称,公司全资子公司广州市联瑞制药有限公司近日收到国家药品监督管理局核准签发的关于羧甲司坦口服溶液的《药品注册证书》。羧甲司坦口服溶液适应症为用于治疗慢性支气管炎、支气管哮喘等疾病引起的痰液粘稠、咳痰困难患者。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060400031673.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300723"],"gpt_icon":0},{"id":"2540050024","title":"一品红最新公告:全资子公司获得间苯三酚注射液注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2540050024","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540050024?lang=zh_cn&edition=full","pubTime":"2025-06-04 19:10","pubTimestamp":1749035414,"startTime":"0","endTime":"0","summary":"一品红(300723.SZ)公告称,公司全资子公司广州市联瑞制药有限公司近日收到国家药品监督管理局核准签发的间苯三酚注射液的《药品注册证书》。该药品适应症为消化系统和胆道功能障碍引起的急性痉挛性疼痛等。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060400031669.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300723"],"gpt_icon":0},{"id":"2539837977","title":"每周股票复盘:一品红(300723)全资子公司取得药品生产许可证","url":"https://stock-news.laohu8.com/highlight/detail?id=2539837977","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539837977?lang=zh_cn&edition=full","pubTime":"2025-05-31 17:25","pubTimestamp":1748683512,"startTime":"0","endTime":"0","summary":"截至2025年5月30日收盘,一品红报收于49.65元,较上周的49.45元上涨0.4%。本周,一品红5月30日盘中最高价报55.33元,股价触及近一年最高点。本周关注点公司公告汇总: 广东瑞石制药科技有限公司取得药品生产许可证,生产原料药公司公告汇总广东瑞石制药科技有限公司近期取得了广东省药品监督管理局下发的药品生产许可证。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025053100010746.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300723"],"gpt_icon":0},{"id":"2538037428","title":"一品红最新公告:全资子公司瑞石制药取得药品生产许可证","url":"https://stock-news.laohu8.com/highlight/detail?id=2538037428","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538037428?lang=zh_cn&edition=full","pubTime":"2025-05-28 16:30","pubTimestamp":1748421003,"startTime":"0","endTime":"0","summary":"一品红(300723.SZ)公告称,公司全资子公司广东瑞石制药科技有限公司于近期取得了广东省药品监督管理局下发的药品生产许可证,生产地址和生产范围为广东省韶关市翁源县翁城镇制造工业园 HC0305-04地块;原料药(氘泊替诺雷)。本次取得《药品生产许可证》预期不会对公司当前业绩产生重大影响,相关产品待获得药品上市批准文号后方可进行商业化生产。取得《药品生产许可证》仅是新药研发进展中阶段性里程碑,后续临床试验阶段是否顺利、能否获得生产批件、具备上市资格尚存在诸多不确定。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025052800025087.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300723","BK1191","BK0239","BK1574","01477"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1752966402391,"stockEarnings":[{"period":"1week","weight":0.3213},{"period":"1month","weight":0.3113},{"period":"3month","weight":0.8162},{"period":"6month","weight":2.9946},{"period":"1year","weight":2.4504},{"period":"ytd","weight":2.9338}],"compareEarnings":[{"period":"1week","weight":0.0069},{"period":"1month","weight":0.043},{"period":"3month","weight":0.0787},{"period":"6month","weight":0.0903},{"period":"1year","weight":0.1872},{"period":"ytd","weight":0.0545}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"一品红药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"17111人(较上一季度增加36.61%)","perCapita":"24408股","listingDate":"2017-11-16","address":"广东省广州市黄埔区广州国际生物岛寰宇一路27号云润大厦17层","registeredCapital":"45169万元","survey":" 一品红药业集团股份有限公司的主营业务是药品的研发、生产和销售。公司的主要产品是化学药(含原料药和制剂)、特色中成药等。","listedPrice":17.05},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"一品红(300723)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供一品红(300723)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"一品红,300723,一品红股票,一品红股票老虎,一品红股票老虎国际,一品红行情,一品红股票行情,一品红股价,一品红股市,一品红股票价格,一品红股票交易,一品红股票购买,一品红股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"一品红(300723)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供一品红(300723)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}